VMD: VMD requests for delay in submitting the 2023 reviewed semiannual financial statements
VMD: VMD requests for delay in submitting the 2023 reviewed semiannual financial statements
VMD requests for delay in submitting the 2023 reviewed semiannual financial statements of Vimedimex Medi – Pharma Joint Stock Company as follows:
Attached Files: |
20230906_VMD 230906 VMD requests for delay in submitting the 2023 reviewed semiannual financial statements - QN.pdf |
HOSE